Pnc Financial Services »

Dianthus Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 37k 30.00

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Erie Indty Cl A (ERIE)
Ishares Tr Msci Usa Qlt F (QUAL)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Qtly Div Gr (DGRW)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Exxon Mobil Corporation (XOM)
Ishares Tr Msci Intl Qual (IQLT)

View all positions for Pnc Financial Services

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics